Written from the studies on PubMed, searched on 2026. nov. 11.. Every number below comes from a study listed under Sources. The text was written by AI from these studies; each sentence names the studies it comes from.
The claim
Mucuna pruriens, a tropical bean, is said to treat Parkinson's disease.
Where research stands
We found 47 published papers on Mucuna pruriens and Parkinson disease. They were published between 1978 and 2026. 4 of them are studies in people. At least 40 people took part. 4 of them compared people who got it with a group that did not. 15 were studies in animals, and 3 were only in cells in the lab. 5 papers are reviews that sum up other studies.
- 4In people4 with a comparison group
- 15In animals
- 3Only in the lab
What the studies found
Trials in people
Four small trials in people tested Mucuna against standard Parkinson's medicine. [1][2][3][4] In an 18-person test, a high dose worked better than standard medicine, with fewer side effects. [2] In a 14-person trial, half of those on Mucuna stopped early because of side effects. [3] In a 32-person trial over 12 months, results were similar to standard medicine. [4] Side effects were more common with Mucuna: 56 in 100 vs 37.5 in 100. [4]
Other studies in people
One person using Mucuna on their own took more medicine than needed. [5] Five Mucuna supplements held less levodopa than their makers stated. [6]
Reviews
A review of 5 trials found mostly better symptoms, but three trials were low quality. [7] Reviews say long-term safety is not well known, so more data are needed. [8][9] Using it alone without supervision has been linked to movement and mental problems. [8]
In animals
In mice, Mucuna improved movement but did not restore damaged brain cells. [10] Results in animals do not always hold in people.
In the lab
Lab work found some protective effects in cells and small animals. [14] Traditional preparation changed the plant's chemicals, and 51 had links to toxicity. [15]
Verdict
Four small trials in people found Mucuna worked about as well as standard medicine. [1][2][3][4] But many had side effects, the trials were small and short, and long-term safety is unknown. [3][4][8] So the claim is partly true. [7]
Partly true means: people did well, but no fair test with a comparison group has shown it yet. Or only part of the claim holds. How we rate claims
What this means for you: A study in people is not proof that it helps you. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.
Sources
- Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.2004 · J Neurol Neurosurg Psychiatry · Randomised trial
- Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.2017 · Neurology · Randomised trial
- Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study.2018 · Parkinsonism Relat Disord · Randomised trial
- Mucuna pruriens in untreated Parkinson's disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial.2026 · J Parkinsons Dis · Randomised trial
- Dopamine Dysregulation Syndrome in Parkinson's Disease.2025 · Sr Care Pharm · Other paper
- Analysis of amino acids in Mucuna pruriens supplements using hydrophilic interaction liquid chromatography-tandem mass spectrometry.2026 · Amino Acids · Other paper
- Mucuna pruriens Treatment for Parkinson Disease: A Systematic Review of Clinical Trials.2025 · Parkinsons Dis · Review
- "To Bean or Not to Bean": Therein lie the hype and the hope. Advice to people with Parkinson in my clinic about Mucuna pruriens.2026 · J Parkinsons Dis · Review
- Mucuna pruriens to treat Parkinson's disease in low-income countries: Recommendations and practical guidelines from the farmer to clinical trials. Paving the way for future use in clinical practice.2024 · Parkinsonism Relat Disord · Review
- Recovery of motor function is associated with rescue of glutamate biomarkers in the striatum and motor cortex following treatment with Mucuna pruriens in a murine model of Parkinsons disease.2023 · Mol Cell Neurosci · In animals
- Effects of Mucuna pruriens (L.) DC. and Levodopa in Improving Parkinson's Disease in Rotenone Intoxicated Mice.2024 · Curr Issues Mol Biol · In animals
- n-Propanol extract of boiled and fermented koro benguk (Mucuna pruriens seed) shows a neuroprotective effect in paraquat dichloride-induced Parkinson's disease rat model.2018 · Vet World · In animals
- Chitosan functionalized selenium nanoconjugates of Mucuna pruriens as a nanotherapeutic approach for Parkinson's disease.2026 · Discov Nano · In animals
- Levodopa-Reduced Mucuna pruriens Seed Extract Shows Neuroprotective Effects against Parkinson's Disease in Murine Microglia and Human Neuroblastoma Cells, Caenorhabditis elegans, and Drosophila melanogaster.2018 · Nutrients · In the lab
- Impact of Ayurvedic purification (Shodhana) on Mucuna pruriens for primary health care in Parkinson's disease: phytochemical profile, bioavailability of L-DOPA, and comparative UPLC-MS/MS QTOF-Caco-2 analysis.2026 · Front Med (Lausanne) · In the lab
- Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation of Mucuna pruriens for Parkinson's Disease Treatment.2026 · Curr Drug Targets · Other paper
